Fig. 7From: SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivityExperimental validation results. expression of (A) CENPA and (B) CENPN, (C) flow cytometry results showing (C) cell cycle alteration and (D) cancer stem cell percentage after knocking down SNRPD1 or SNRPE in vitro in MDAMB231 cells. ‘GenePharma Silencer Select Negative Control’ was used as the negative control for gene silencingBack to article page